Search - tctmd.com

Displaying 941 - 960 of 2514

Sort: Relevancy | Date

Presentation TCT 2022

TAVR vs SAVR – Case-based Risk Discussion, What Do I Need to Know?: Case-based Lifelong Management of Aortic Stenosis

Presenter: Michael Querijero

September 16, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

Presentation TCT 2021

Prosthetic Valve Selection and Implant Techniques for Prevention of PPM/High Residual Gradients Following SAVR, TAVR, or Valve-in-Valve

Presenter: David Wood

November 06, 2021

Presentation TCT 2021

Special Considerations of Valve Hemodynamics and Prosthesis-Patient Mismatch Following Valve-in-Valve

Presenter: Janarthanan Sathananthan

November 06, 2021

Presentation TCT 2021

Special Considerations of Valve Hemodynamics and Prosthesis-Patient Mismatch in the Small Annulus

Presenter: Howard Herrmann

November 06, 2021

Presentation TCT 2021

What Is the Definition and Clinical Impact of Prosthesis-Patient Mismatch in TAVR

Presenter: Philippe Pibarot

November 06, 2021

Presentation TCT 2021

Early Discharge After TAVR

Presenter: Amar Krishnaswamy

November 05, 2021

Presentation TCT 2021

Evidence-Based Antiplatelet and Antithrombotic Therapy for TAVR

Presenter: Stephan Windecker

November 05, 2021

Presentation TCT 2021

TCT 532: Kinked TAVR

Presenter: Sunny Goel

November 05, 2021

Presentation TCT 2021

Understanding SVD and BVF: VARC-3 and European Definitions

Presenter: Philippe Pibarot

November 05, 2021

Presentation TCT 2021

Rationale of Earlier AS Treatment: Asymptomatic Severe AS and Moderate AS

Presenter: Nicolas Van Mieghem

November 05, 2021

Presentation TCT 2021

Routine Use Is Entirely Justifiable

Presenter: Axel Linke

November 05, 2021

Presentation TCT 2021

Not Indicated for Routine TAVR

Presenter: John K. Forrest

November 05, 2021

Presentation TCT 2021

Minimal Impact on Clinical Endpoints

Presenter: Hemal Gada

November 05, 2021

Presentation TCT 2021

Important Consideration for Valve Selection

Presenter: Tamim M. Nazif

November 05, 2021

Presentation TCT 2021

TCT 612: Unprotected Left Main Disease and TAVR: What Do We Do First?

Presenter: Ronald Rivas Gálvez

November 05, 2021

Presentation TCT 2021

Clinically Significant Phenomenon With Consequences

Presenter: Raj Makkar

November 05, 2021

Presentation TCT 2021

AorticLab GEMINI - Functional Recovery of Stenotic Aortic Valve With A Double Ultrasound Wave Effect

Presenter: Federico De Marco

November 05, 2021

Presentation TCT 2021

Longer-term Concerns: What Comes Next?

Presenter: Tsuyoshi Kaneko

November 05, 2021

Presentation TCT 2021

First Dedicated Transcatheter Leaflet Splitting Device From Bench to FIH (ShortCut)

Presenter: Susheel Kodali

November 05, 2021

Advertisement

TAVR vs SAVR – Case-based Risk Discussion, What Do I Need to Know?: Case-based Lifelong Management of Aortic Stenosis

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Prosthetic Valve Selection and Implant Techniques for Prevention of PPM/High Residual Gradients Following SAVR, TAVR, or Valve-in-Valve

Special Considerations of Valve Hemodynamics and Prosthesis-Patient Mismatch Following Valve-in-Valve

Special Considerations of Valve Hemodynamics and Prosthesis-Patient Mismatch in the Small Annulus

What Is the Definition and Clinical Impact of Prosthesis-Patient Mismatch in TAVR

Early Discharge After TAVR

Evidence-Based Antiplatelet and Antithrombotic Therapy for TAVR

TCT 532: Kinked TAVR

Understanding SVD and BVF: VARC-3 and European Definitions

Rationale of Earlier AS Treatment: Asymptomatic Severe AS and Moderate AS

Routine Use Is Entirely Justifiable

Not Indicated for Routine TAVR

Minimal Impact on Clinical Endpoints

Important Consideration for Valve Selection

TCT 612: Unprotected Left Main Disease and TAVR: What Do We Do First?

Clinically Significant Phenomenon With Consequences

AorticLab GEMINI - Functional Recovery of Stenotic Aortic Valve With A Double Ultrasound Wave Effect

Longer-term Concerns: What Comes Next?

First Dedicated Transcatheter Leaflet Splitting Device From Bench to FIH (ShortCut)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content